Psoriasis is a highly visible chronic disease with a substantial impact on quality of life.
Objective:
The purpose of this review is to understand how psoriasis experience stigmatization. A greater understanding of this may help dermatologists improve treatment strategies for their patients.
Methods:
A MEDLINE search was performed for the terms stigmatization and psoriasis.
Results:
Stigmatization is common in psoriasis and has a much greater social and psychological impact than even the extent and severity of skin involvement. Patients with psoriasis may experience stigma in different ways. Psoriasis is more highly stigmatized than most other skin diseases. Lack of knowledge about psoriasis on part of the general public is a significant contributor to how patients with psoriasis are stigmatized by others.
Conclusion:
Stigma is a significant contributor to negative quality of life in patients with psoriasis. Stigma is an important aspect of disease to consider when formulating optimal psoriasis treatment strategy.
MichalekIMLoringBJohnSM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205–212.
2.
RappSRFeldmanSRExumMLFleischerABJrReboussinDM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3 pt 1):401–407.
3.
GolpourMHosseiniSHKhademlooM. Depression and anxiety disorders among patients with psoriasis: a hospital-based case-control study. Dermatol Res Pract. 2012;2012:381905.
4.
ScamblerGHeijndersMvan BrakelWH. Understanding and tackling health-related stigma. Psychol Health Med. 2006;11(3):269–270.
5.
BhosleMJKulkarniAFeldmanSRBalkrishnanR. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006;4:35.
6.
JoblingRNaldiL. Assessing the impact of psoriasis and the relevance of qualitative research. J Invest Dermatol. 2006;126(7):1438–1440.
7.
GinsburgIHLinkBG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol. 1989;20(1):53–63.
8.
LuYDullerPVan Der ValkPEversA. Helplessness as predictor of perceived stigmatization in patients with psoriasis and atopic dermatitis. Dermatol Psychosom. 2003;4(3):146–150.
9.
Schmid-OttGJaegerBKuensebeckHWOttRLamprechtF. Dimensions of stigmatization in patients with psoriasis in a “Questionnaire on Experience with Skin Complaints’. Dermatology. 1996;193(4):304–310.
10.
Schmid-OttGKuensebeckHWJaegerB. Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Derm Venereol. 1999;79(6):443–447.
11.
GhorbanibirganiAFallahi-KhoshknabMZareaKAbediH. The lived experience of psoriasis patients from social stigma and rejection: a qualitative study. Iran Red Crescent Med J. 2016;18(7):e27893.
12.
van BeugenSvan MiddendorpHFerwerdaM. Predictors of perceived stigmatization in patients with psoriasis. Br J Dermatol. 2017;176(3):687–694.
13.
HrehorowESalomonJMatusiakLReichASzepietowskiJC. Patients with psoriasis feel stigmatized. Acta Derm Venereol. 2012;92(1):67–72.
14.
HawroMMaurerMWellerK. Lesions on the back of hands and female gender predispose to stigmatization in patients with psoriasis. J Am Acad Dermatol. 2017;76(4):648–654.e2.
15.
Schmid-OttGKunsebeckHWJagerB. Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol. 2005;85(1):27–32.
16.
ZieciakTRzepaTKrolJZabaR. Stigmatization feelings and depression symptoms in psoriasis patients. Psychiatr Pol. 2017;51(6):1153–1163.
17.
PerrottSBMurrayAHLoweJMathiesonCM. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiol Behav. 2000;70(5):567–571.
18.
DoniganJMPascoeVLKimballAB. Psoriasis and herpes simplex virus are highly stigmatizing compared with other common dermatologic conditions: a survey-based study. J Am Acad Dermatol. 2015;73(3):525–526.
19.
HaliouaBSid-MohandDRousselMEMaury-le-BretonAde FontaubertAStalderJF. Extent of misconceptions, negative prejudices and discriminatory behaviour to psoriasis patients in France. J Eur Acad Dermatol Venereol. 2016;30(4):650–654.
20.
GinsburgIHLinkBG. Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol. 1993;32(8):587–591.
21.
Schmid-OttGSchallmayerSCalliessIT. Quality of life in patients with psoriasis and psoriasis arthritis with a special focus on stigmatization experience. Clin Dermatol. 2007;25(6):547–554.
22.
BewleyABurrageDMErsserSJHansenMWardC. Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study. J Eur Acad Dermatol Venereol. 2014;28(6):763–770.
23.
MaginPAdamsJHeadingGPondDSmithW. Experiences of appearance-related teasing and bullying in skin diseases and their psychological sequelae: results of a qualitative study. Scand J Caring Sci. 2008;22(3):430–436.
24.
GuptaMAGuptaAKWatteelGN. Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. Cutis. 1998;61(6):339–342.
25.
RamsayBO’ReaganM. A survey of the social and psychological effects of psoriasis. Br J Dermatol. 1988;118(2):195–201.
26.
VardyDBesserAAmirMGesthalterBBitonABuskilaD. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002;147(4):736–742.
27.
JankowiakBSekmistrzSKowalewskaBNiczyporukWKrajewska-KułakE. Satisfaction with life in a group of psoriasis patients. Postepy Dermatol Alergol. 2013;30(2):85–90.
28.
BohmDStock GissendannerSBangemannK. Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. J Eur Acad Dermatol Venereol. 2013;27(2):220–226.
29.
GuptaMAGuptaAK. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol. 1995;34(10):700–703.
30.
RichardsHLFortuneDGGriffithsCEMainCJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res. 2001;50(1):11–15.
31.
PremkumarRKarBRajanPRichardJ. Major precipitating factors for stigma among stigmatized vitiligo and psoriasis patients with brown-black skin shades. Indian J Dermatol Venereol Leprol. 2013;79(5):703–705.
32.
de JagerMEDe JongEMEversAWVan De KerkhofPCSeygerMM. The burden of childhood psoriasis. Pediatr Dermatol. 2011;28(6):736–737.
33.
JankowiakBKowalewskaBFiodaravich KhvorikDKrajewska-KulakENiczyporukW. The level of stigmatization and depression of patients with psoriasis. Iran J Public Health. 2016;45(5):690–692.
34.
RichardsHLFortuneDGMainCJGriffithsCE. Stigmatization and psoriasis. Br J Dermatol. 2003;149(1):209–211.
35.
AlpsoyEPolatMFettahlioGlu-KaramanB. Internalized stigma in psoriasis: a multicenter study. J Dermatol. 2017;44(8):885–891.
36.
LakutaPMarcinkiewiczKBergler-CzopBBrzezinska-WcisloL. The relationship between psoriasis and depression: a multiple mediation model. Body Image. 2016;19:126–132.
37.
SchneiderGHeuftGHockmannJ. Determinants of social anxiety and social avoidance in psoriasis outpatients. J Eur Acad Dermatol Venereol. 2013;27(3):383–386.
38.
ReichAWelz-KubiakKRamsL. Apprehension of the disease by patients suffering from psoriasis. Postepy Dermatol Alergol. 2014;31(5):289–293.
39.
LakutaPMarcinkiewiczKBergler-CzopBBrzezinska-WcisloL. How does stigma affect people with psoriasis?Postepy Dermatol Alergol. 2017;34(1):36–41.
40.
JanowskiKSteudenSPietrzakA. Social support and adaptation to the disease in men and women with psoriasis. Arch Dermatol Res. 2012;304(6):421–432.
41.
LakutaPMarcinkiewiczKBergler-CzopBBrzezinska-WcisloLSlomianA. Associations between site of skin lesions and depression, social anxiety, body-related emotions and feelings of stigmatization in psoriasis patients. Postepy Dermatol Alergol. 2018;35(1):60–66.
42.
LakutaPPrzybyla-BasistaH. Toward a better understanding of social anxiety and depression in psoriasis patients: the role of determinants, mediators, and moderators. J Psychosom Res. 2017;94:32–38.
43.
LeiboviciVCanettiLYahalomiS. Well being, psychopathology and coping strategies in psoriasis compared with atopic dermatitis: a controlled study. J Eur Acad Dermatol Venereol. 2010;24(8):897–903.
44.
van BeugenSMaasJvan LaarhovenAI. Implicit stigmatization-related biases in individuals with skin conditions and their significant others. Health Psychol. 2016;35(8):861–865.
45.
PichaimuthuRRamaswamyPBikashKJosephR. A measurement of the stigma among vitiligo and psoriasis patients in India. Indian J Dermatol Venereol Leprol. 2011;77(3):300–306.
46.
DimitrovDSzepietowskiJC. Instruments to assess stigmatization in dermatology. Postepy Hig Med Dosw (Online). 2017;71(0):901–905.
47.
FinlayAYKhanGK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216.
48.
FeldmanSRKooJYMenterABagelJ. Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol. 2005;53(1):101–107.
